Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Population Health Management discusses latest information on shingles and PHN

Population Health Management discusses latest information on shingles and PHN

Favorable preliminary results from XenoPort’s XP23829 Phase 1 trial on RRMS, psoriasis

Favorable preliminary results from XenoPort’s XP23829 Phase 1 trial on RRMS, psoriasis

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Depomed submits Serada NDA with FDA for treatment of menopausal hot flashes

Depomed submits Serada NDA with FDA for treatment of menopausal hot flashes

Treatments for peripheral neuropathic pain compared

Treatments for peripheral neuropathic pain compared

Pfizer’s Lyrica does not affect reproductive function in healthy males

Pfizer’s Lyrica does not affect reproductive function in healthy males

XenoPort initiates XP23829 Phase 1 study in healthy adults

XenoPort initiates XP23829 Phase 1 study in healthy adults

Once-daily Gralise significantly reduces pain intensity in PHN patients

Once-daily Gralise significantly reduces pain intensity in PHN patients

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Delaware district court upholds Pfizer's patents for LYRICA to treat pain and seizures

Delaware district court upholds Pfizer's patents for LYRICA to treat pain and seizures

Regnite to treat primary restless legs syndrome launched in Japan

Regnite to treat primary restless legs syndrome launched in Japan

Noven Pharmaceuticals provides update on status of generic Lidoderm ANDA

Noven Pharmaceuticals provides update on status of generic Lidoderm ANDA

Depomed acquires all rights to Zipsor from Xanodyne

Depomed acquires all rights to Zipsor from Xanodyne

Pfizer receives FDA approval for Lyrica to manage neuropathic pain associated with SCI

Pfizer receives FDA approval for Lyrica to manage neuropathic pain associated with SCI

AMS announces FDA clearance of MEVION S250 Proton Therapy System

AMS announces FDA clearance of MEVION S250 Proton Therapy System

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

Endo, Watson reach agreement to resolve two LIDODERM patent infringement lawsuits

Endo, Watson reach agreement to resolve two LIDODERM patent infringement lawsuits

Pfizer announces results from Lyrica clinical studies on fibromyalgia

Pfizer announces results from Lyrica clinical studies on fibromyalgia